Book contents
- Frontmatter
- Contents
- Contributors
- Series Foreword
- Preface to Cancer of the Ovary
- 1 Epidemiology of Ovarian Cancer
- 2 The Pathological Features of Ovarian Neoplasia
- 3 Ovarian Cancer Screening
- 4 Surgical Management of Patients with Epithelial Ovarian Cancer
- 5 Medical Treatment of Ovarian Carcinoma
- 6 Ultrasound in Ovarian Carcinoma
- 7 MR Imaging in Ovarian Cancer
- 8 CT in Carcinoma of the Ovary
- 9 PET and PET/CT in Ovarian Cancer
- Index
- Plate section
- References
3 - Ovarian Cancer Screening
Published online by Cambridge University Press: 11 September 2009
- Frontmatter
- Contents
- Contributors
- Series Foreword
- Preface to Cancer of the Ovary
- 1 Epidemiology of Ovarian Cancer
- 2 The Pathological Features of Ovarian Neoplasia
- 3 Ovarian Cancer Screening
- 4 Surgical Management of Patients with Epithelial Ovarian Cancer
- 5 Medical Treatment of Ovarian Carcinoma
- 6 Ultrasound in Ovarian Carcinoma
- 7 MR Imaging in Ovarian Cancer
- 8 CT in Carcinoma of the Ovary
- 9 PET and PET/CT in Ovarian Cancer
- Index
- Plate section
- References
Summary
Introduction
Ovarian cancer remains not only the commonest but also the most lethal gynaecological malignancy in the UK (Table 3.1 [1]).
Despite advances in molecular biology, surgery and chemotherapy, ovarian cancer remains a difficult condition to manage and long-term survival rates have hardly improved since the 1970s [2]. The poor prognosis of the disease is believed to be due to the fact that more than 70% of women present with disease spread beyond the ovaries (Table 3.2 [3]). This probably reflects the absence of major symptoms in early stage disease, due to the location of the ovaries, which results in little interference with surrounding structures until ovarian enlargement is considerable or metastatic disease supervenes. When symptoms occur, they may be non-specific, requiring frequent consultations with a GP before further investigation is prompted. However, it should be noted that most stage I ovarian cancers have an extremely good prognosis following surgery alone. Detection of early stage disease may therefore offer an opportunity to reduce mortality. However, so far, no screening protocol for ovarian cancer has been shown to achieve this aim. Nevertheless, developments in ultrasound and tumour marker technology, combined with more sophisticated approaches to interpretation have improved the performance of the potential screening strategies to levels which may reduce mortality. These strategies are currently being tested in two large randomised controlled trials of ovarian cancer screening; one in the UK [4] and one in the USA [5]. However, neither of these is expected to report before 2012.
- Type
- Chapter
- Information
- Cancer of the Ovary , pp. 47 - 68Publisher: Cambridge University PressPrint publication year: 2006
References
- 1
- Cited by